What is APOE4? A plain-language primer
APOE4 is the most common genetic risk factor for late-onset Alzheimer’s. What the gene does, what carrying one or two copies means, and the crucial things it does not mean.
Updated June 16, 2026 8 min
Deep Dives
Understand APOE4, and what to do about it
These are not skim-and-forget overviews. Each deep dive goes into the mechanism, the actual numbers in context, and what the evidence means for a carrier specifically. New to APOE4? Start with the Basics group below.
APOE4 Basics
View all →The APOE genotypes explained: from 2/2 to 4/4
You inherit one APOE allele from each parent. What each of the six pairs, from protective 2/2 to higher-risk 4/4, actually means for risk, in plain numbers.
Updated June 16, 2026 8 min
How to get tested for APOE4, and whether you should
Consumer kits, clinical tests, and genetic counseling compared, the insurance and privacy trade-offs, and how to decide whether learning your APOE status is right for you.
Updated June 16, 2026 8 min
Brain & Cognition
View all →APOE4 and Alzheimer’s risk: what the numbers actually mean
Relative risk, absolute risk, and age of onset: how to read the scary statistics about APOE4 and Alzheimer’s, with real ranges and the hopeful part that gets buried.
Updated June 16, 2026 9 min
How APOE4 affects the brain
APOE4 influences how the brain clears amyloid, handles tau, manages inflammation, regulates neural activity, and maintains its blood vessels. A plain-language tour of the leading mechanisms.
Updated July 24, 2026 11 min
APOE4, women, and sex differences in risk
Evidence suggests APOE4 carries a different risk profile for women than men, especially at certain ages. What the research shows, the menopause angle, and its limits.
Updated June 16, 2026 8 min
Heart & Vascular
View all →APOE4, cholesterol, and cardiovascular risk
APOE4 does not only affect the brain. It shapes how your body handles cholesterol, which makes cardiovascular health the most concrete, trackable, and treatable lever carriers have.
Updated June 16, 2026 9 min
ApoB vs. LDL-C: the number to actually watch
Standard panels report LDL-C, but ApoB counts the particles that drive artery disease. Why the distinction matters for APOE4 carriers, and how to get and read it.
Updated June 16, 2026 8 min
Blood pressure and brain health
High blood pressure is one of the best-established modifiable risk factors for dementia. Why it matters so much for APOE4 carriers, the numbers, and how to keep it in range.
Updated June 16, 2026 8 min
Diet & Nutrition
View all →APOE4 and saturated fat: the ongoing debate
One of the most argued-about questions for carriers. The mechanism, what the evidence actually supports, how much is reasonable, and why measuring beats guessing.
Updated June 16, 2026 9 min
The Mediterranean and MIND diets: what the evidence shows
Two dietary patterns dominate the brain-health conversation. What the research actually supports, the specific foods and frequencies, and how to apply it as an APOE4 carrier.
Updated June 16, 2026 9 min
Omega-3s, DHA, and the APOE4 wrinkle
Omega-3 fats matter for the brain, but the evidence in APOE4 carriers has a real twist. The mechanism, the dose question, the right form, and what is still uncertain.
Updated June 16, 2026 9 min
Exercise & Fitness
View all →Exercise and APOE4: the strongest lever you control
Of all the modifiable factors, physical activity has some of the most consistent evidence for the APOE4 brain and heart. The mechanism, the dose, and how to actually start.
Updated June 16, 2026 9 min
Aerobic vs. strength training: what to do and how much
You need both. A practical guide to combining cardio and resistance training for brain, heart, and metabolic health, with sensible weekly targets and how to program them.
Updated June 16, 2026 9 min
Zone 2, VO₂max, and the longevity case for cardio
Two fitness ideas jumped from the lab to the podcast circuit. What zone 2 and VO₂max really mean, how to train them without gadgets, and why fitness behaves like a vital sign.
Updated June 16, 2026 8 min
Sleep & Stress
View all →Sleep, the glymphatic system, and APOE4
Why sleep keeps coming up in Alzheimer’s research, what the glymphatic system is, the two-way street between sleep and amyloid, and practical sleep priorities for carriers.
Updated June 16, 2026 8 min
Sleep apnea and cognitive risk: the underdiagnosed lever
Obstructive sleep apnea is common, often silent, harmful to the brain and heart, and very treatable. Why it deserves attention from APOE4 carriers, and how to get evaluated.
Updated June 16, 2026 8 min
Stress, cortisol, and the brain
Chronic stress touches blood pressure, sleep, mood, and behavior in ways that matter for brain health. The mechanism, and practical, evidence-aligned ways to manage it.
Updated June 16, 2026 8 min
Latest Research
View all →Anti-amyloid drugs (lecanemab, donanemab) and what they mean for carriers
A new class of Alzheimer’s drugs can modestly slow decline, but APOE4 carriers, especially homozygotes, face higher rates of a key side effect. How they work and what to weigh.
Updated June 17, 2026 10 min
The FINGER trial: can lifestyle change the trajectory?
The landmark FINGER study tested whether a combined lifestyle program could protect cognition in at-risk older adults. What it found, the global trials it inspired, and why it matters for carriers.
Updated June 17, 2026 8 min
Blood-based biomarkers for Alzheimer’s: the coming shift
For years, confirming Alzheimer’s biology meant a spinal tap or a PET scan. Blood tests are starting to change that. What they measure, where they stand, and the real caveats.
Updated June 17, 2026 8 min